Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-09 Sale | 2026-02-10 09:00 am | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 17,159 | $21.03 | $360,819 | 491,690 (Direct) | View |
| 2026-02-09 Sale | 2026-02-10 08:59 am | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 3,410 | $21.03 | $71,705 | 140,429 (Direct) | View |
| 2026-02-06 Sale | 2026-02-06 5:54 pm | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 7,412 | $20.62 | $152,835 | 948,849 (Direct) | View |
| 2026-02-06 Sale | 2026-02-06 5:53 pm | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 2,082 | $20.62 | $42,931 | 263,058 (Direct) | View |
| 2025-09-08 Sale | 2025-09-08 6:45 pm | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 157,307 | $16.41 | $2,582,021 | 298,661 (Direct) | View |
| 2025-08-14 Sale | 2025-08-18 5:02 pm | Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director | 57,600 | $15.19 | $875,100 | 191,763 (Direct) | View |
| 2025-07-16 Sale | 2025-07-18 4:30 pm | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 1,296 | $9.285 | $12,033 | 92,450 (Direct) | View |
| 2025-07-16 Sale | 2025-07-18 4:30 pm | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 7,534 | $9.285 | $69,953 | 298,661 (Direct) | View |
| 2025-05-19 Purchase | 2025-05-19 4:04 pm | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 3,000 | $0 | $0 | 93,746 (Direct) | View |
| 2025-05-16 Purchase | 2025-05-19 4:03 pm | Syndax Pharmaceuticals Inc | SNDX | Botwood Nicholas A.J. Head of R&D, CMO | 11,765 | $8.995 | $105,826 | 35,165 (Direct) | View |
| 2025-05-19 Purchase | 2025-05-19 4:02 pm | Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director | 5,000 | $8.99 | $44,950 | 79,000 (Direct) | View |
| 2025-05-19 Purchase | 2025-05-19 4:01 pm | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 10,000 | $9.112 | $91,120 | 100,000 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:10 pm | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 7,814 | $15.05 | $117,564 | 300,121 (Direct) | View |
| 2025-02-10 Sale | 2025-02-12 5:16 pm | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 3,777 | $15.5 | $58,559 | 90,746 (Direct) | View |
| 2025-02-10 Sale | 2025-02-12 5:15 pm | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 13,288 | $15.5 | $206,017 | 300,121 (Direct) | View |
| 2025-02-10 Sale | 2025-02-12 5:13 pm | Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D | 4,618 | $15.5 | $71,597 | 85,095 (Direct) | View |
| 2024-06-14 Purchase | 2024-06-17 09:26 am | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 1,250 | $20.03 | $25,037 | 52,623 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-04 Option Award | 2026-02-06 5:54 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 217,600 | $0 | 948,849 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 5:54 pm | N/A 2036-02-04 | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 440,000 | $20.43 | 948,849 (Direct) | View |
| 2026-01-30 Other | 2026-02-06 5:53 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 1,219 | $8.48 | 263,058 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 5:53 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 52,250 | $0 | 263,058 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 5:53 pm | N/A 2036-02-04 | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 118,000 | $20.43 | 263,058 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 5:16 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Jarrett Jennifer Director | 24,000 | $0 | 114,000 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 4:55 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director | 24,000 | $0 | 103,000 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 4:50 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Botwood Nicholas A.J. Head of R&D, CMO | 60,000 | $0 | 239,865 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 4:50 pm | N/A 2036-02-04 | Syndax Pharmaceuticals Inc | SNDX | Botwood Nicholas A.J. Head of R&D, CMO | 144,700 | $20.43 | 239,865 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 4:14 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director | 48,000 | $0 | 239,763 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 4:13 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Rizo Aleksandra Director | 24,000 | $0 | 49,000 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 4:13 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 24,000 | $0 | 124,000 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-06 4:06 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director | 24,000 | $0 | 114,000 (Direct) | View |
| 2025-12-01 Gift | 2025-12-01 4:30 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 1,224 | $0 | 92,452 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-08 6:45 pm | N/A 2025-09-09 | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 157,307 | $0 | 298,661 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-08 6:45 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 157,307 | $10.9 | 298,661 (Direct) | View |
| 2025-08-14 Exercise | 2025-08-18 5:02 pm | N/A 2025-08-18 | Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director | 57,600 | $0 | 191,763 (Direct) | View |
| 2025-08-14 Exercise | 2025-08-18 5:02 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director | 57,600 | $7.2 | 191,763 (Direct) | View |
| 2025-07-31 Other | 2025-08-07 5:30 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 1,226 | $8.43 | 94,902 (Direct) | View |
Ownership | 2025-05-16 4:16 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Botwood Nicholas A.J. Head of R&D, CMO | 0 | $0 | 238,400 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-17 06:01 am | N/A 2025-06-01 | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 6,074 | $0 | 306,195 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-17 06:01 am | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 6,074 | $7.2 | 306,195 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:10 pm | N/A 2025-06-01 | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 7,814 | $0 | 300,121 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:10 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 7,814 | $7.2 | 300,121 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:45 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D | 41,900 | $0 | 200,213 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:45 pm | N/A 2035-02-05 | Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D | 110,500 | $14.65 | 200,213 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:44 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 41,900 | $0 | 205,023 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:44 pm | N/A 2035-02-05 | Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer | 110,500 | $14.65 | 205,023 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:42 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 149,500 | $0 | 677,409 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:42 pm | N/A 2035-02-05 | Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A Chief Executive Officer | 364,000 | $14.65 | 677,409 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:41 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Podlesak Dennis Director | 50,000 | $0 | 191,763 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:39 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Rizo Aleksandra Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:38 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meury William Director | 25,000 | $0 | 90,000 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:37 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 25,000 | $0 | 90,000 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:35 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Jarrett Jennifer Director | 25,000 | $0 | 90,000 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:34 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director | 25,000 | $0 | 74,000 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-07 4:32 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Legault Pierre Director | 25,000 | $0 | 90,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-16 4:04 pm | N/A 2034-05-15 | Syndax Pharmaceuticals Inc | SNDX | Rizo Aleksandra Director | 35,000 | $0 | 35,000 (Direct) | View |